Phibro Animal Health Corporation (PAHC) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 383.54M | 373.91M | 363.89M | 378.7M | 347.82M | 309.26M | 260.43M | 273.16M | 263.22M | 249.94M | 231.35M | 255.05M |
| Revenue Growth % | 10.27% | 20.9% | 39.73% | 38.63% | 32.14% | 23.73% | 12.57% | 7.1% | 7.14% | 2.17% | -0.5% | -0.08% |
| Cost of Goods Sold | 257.87M | 241.25M | 244.11M | 268.69M | 243.26M | 207.39M | 176.94M | 186.01M | 183.62M | 171.33M | 163.62M | 178.38M |
| COGS % of Revenue | 67.23% | 64.52% | 67.08% | 70.95% | 69.94% | 67.06% | 67.94% | 68.1% | 69.76% | 68.55% | 70.73% | 69.94% |
| Gross Profit | 124.87M | 132.66M | 119.78M | 110.01M | 104.57M | 101.87M | 83.5M | 87.15M | 79.6M | 78.62M | 67.73M | 76.67M |
| Gross Margin % | 32.56% | 35.48% | 32.92% | 29.05% | 30.06% | 32.94% | 32.06% | 31.9% | 30.24% | 31.45% | 29.27% | 30.06% |
| Gross Profit Growth % | 19.42% | 30.22% | 43.46% | 26.23% | 31.37% | 29.58% | 23.28% | 13.67% | 5.37% | 1.59% | -1.34% | -2.24% |
| Operating Expenses | 76.9M | 77.91M | 71.45M | 76.29M | 71.05M | 76.34M | 65.8M | 68.73M | 59.68M | 62.91M | 68.45M | 52.9M |
| OpEx % of Revenue | 20.05% | 20.84% | 19.64% | 20.15% | 20.43% | 24.68% | 25.26% | 25.16% | 22.67% | 25.17% | 29.59% | 20.74% |
| Selling, General & Admin | 76.9M | 77.91M | 71.45M | 76.29M | 71.05M | 76.34M | 65.8M | 68.73M | 59.68M | 62.91M | 68.45M | 52.9M |
| SG&A % of Revenue | 20.05% | 20.84% | 19.64% | 20.15% | 20.43% | 24.68% | 25.26% | 25.16% | 22.67% | 25.17% | 29.59% | 20.74% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 47.98M | 54.41M | 47.89M | 33.72M | 33.52M | 25.53M | 17.7M | 18.42M | 19.92M | 15.7M | -726K | 23.77M |
| Operating Margin % | 12.51% | 14.55% | 13.16% | 8.9% | 9.64% | 8.26% | 6.8% | 6.74% | 7.57% | 6.28% | -0.31% | 9.32% |
| Operating Income Growth % | 43.14% | 113.11% | 170.59% | 83.09% | 68.21% | 62.62% | 2537.88% | -22.51% | 7.39% | -0.9% | -105.31% | 3.85% |
| EBITDA | 60.42M | 67.31M | 60.72M | 46.13M | 46.13M | 37.11M | 26.7M | 27.62M | 29.12M | 24.61M | 8.14M | 32.34M |
| EBITDA Margin % | 15.75% | 18% | 16.69% | 12.18% | 13.26% | 12% | 10.25% | 10.11% | 11.06% | 9.85% | 3.52% | 12.68% |
| EBITDA Growth % | 30.98% | 81.38% | 127.39% | 67.03% | 58.42% | 50.77% | 227.85% | -14.6% | 7.68% | 1.1% | -63.2% | 3.35% |
| D&A (Non-Cash Add-back) | 12.45M | 12.89M | 12.83M | 12.41M | 12.62M | 11.57M | 9M | 9.2M | 9.2M | 8.91M | 8.87M | 8.57M |
| EBIT | 43.19M | 49.48M | 49.75M | 32.3M | 38.77M | 14M | 17.79M | 12.14M | 18.31M | 8.97M | -6.66M | 26.68M |
| Net Interest Income | -10.63M | -12.34M | -13M | -8.04M | -12.8M | -8.38M | -7.64M | -4.48M | -8.22M | -8.3M | -8.13M | -7.87M |
| Interest Income | 250K | 725K | 484K | 418K | 298K | 782K | 531K | 1.26M | 1.07M | 1.06M | 1.08M | 948K |
| Interest Expense | 10.88M | 13.06M | 13.48M | 8.46M | 13.1M | 9.16M | 8.17M | 5.74M | 9.29M | 9.37M | 9.21M | 8.81M |
| Other Income/Expense | -15.66M | -17.99M | -11.62M | -9.87M | -3.83M | -20.7M | -8.08M | -12.01M | -7M | -12.14M | -11.25M | -2.33M |
| Pretax Income | 32.31M | 36.42M | 36.27M | 23.85M | 29.69M | 4.84M | 9.62M | 6.41M | 12.92M | 3.56M | -11.98M | 21.44M |
| Pretax Margin % | 8.42% | 9.74% | 9.97% | 6.3% | 8.54% | 1.56% | 3.69% | 2.35% | 4.91% | 1.43% | -5.18% | 8.41% |
| Income Tax | 8.29M | 8.97M | 9.74M | 6.62M | 8.81M | 1.65M | 2.65M | 5.66M | 4.52M | 2.29M | -3.96M | 9.94M |
| Effective Tax Rate % | 25.65% | 24.61% | 26.86% | 27.77% | 29.67% | 34.17% | 27.49% | 88.26% | 34.96% | 64.26% | 33.09% | 46.37% |
| Net Income | 24.02M | 27.46M | 26.53M | 17.22M | 20.88M | 3.19M | 6.97M | 752K | 8.4M | 1.27M | -8.02M | 11.5M |
| Net Margin % | 6.26% | 7.34% | 7.29% | 4.55% | 6% | 1.03% | 2.68% | 0.28% | 3.19% | 0.51% | -3.46% | 4.51% |
| Net Income Growth % | 15.06% | 762.13% | 280.32% | 2190.43% | 148.42% | 150% | 187.02% | -93.46% | -16.3% | -82.33% | -307.86% | 53.57% |
| Net Income (Continuing) | 24.02M | 27.46M | 26.53M | 17.22M | 20.88M | 3.19M | 6.97M | 752K | 8.4M | 1.27M | -8.02M | 11.5M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.59 | 0.67 | 0.65 | 0.42 | 0.51 | 0.08 | 0.17 | 0.02 | 0.21 | 0.03 | -0.20 | 0.28 |
| EPS Growth % | 15.69% | 737.5% | 282.35% | 2158.06% | 142.86% | 166.67% | 185% | -93.36% | -16% | -83.33% | -300% | 55.56% |
| EPS (Basic) | 0.59 | 0.68 | 0.65 | 0.42 | 0.52 | 0.08 | 0.17 | 0.02 | 0.21 | 0.03 | -0.20 | 0.28 |
| Diluted Shares Outstanding | 41.04M | 40.96M | 40.88M | 40.7M | 40.71M | 40.72M | 40.58M | 40.52M | 40.52M | 40.5M | 40.5M | 40.5M |
| Basic Shares Outstanding | 40.55M | 40.53M | 40.53M | 40.5M | 40.5M | 40.5M | 40.5M | 40.5M | 40.5M | 40.5M | 40.5M | 40.5M |
| Dividend Payout Ratio | 20.26% | 17.71% | 18.34% | 28.24% | 23.3% | 152.59% | 69.68% | 646.41% | 57.82% | 381.55% | - | 42.28% |